(Q40233929)

English

Point source concentration of GDNF may explain failure of phase II clinical trial

scientific article published on 7 September 2006

Statements

Point source concentration of GDNF may explain failure of phase II clinical trial (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit